PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 1992Circulation153 citations

Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion.

View Full Paper
DGDavid García‐DoradoPTPierre ThérouxJDJason M. Duran

Structured PICO

Does selective intracoronary infusion of BDM reduce infarct size and modify infarct geometry in a pig model of coronary occlusion and reperfusion?

P
Population
57 pigs in an open-chest model (10 for control state regional function, 40 for 51-minute coronary occlusion followed by reperfusion, 7 for basal state coronary blood flow)
I
Intervention
Selective intracoronary infusion of 2,3-butanedione monoxime (BDM)
C
Comparator
Control infusion
O
Outcome
Infarct size/area at risk ratio, regional myocardium function, and infarct histology/geometry after 24 hours of reperfusionsurrogate

Inhibition of the contractile apparatus with intracoronary BDM during reperfusion reduces infarct size and contraction band necrosis in a porcine model, suggesting contracture plays a role in reperfusion-induced cell death.

Abstract

BACKGROUND: Myocardial reperfusion is associated with calcium overload and cell contracture, mechanisms that may precipitate cell death. In this study, we tested the hypothesis that in vivo inhibition of this contracture could lead to cell preservation in an open-chest large animal model. METHODS AND RESULTS: Regional myocardium function was measured during a selective intracoronary infusion of 2,3-butanedione monoxime (BDM), a specific inhibitor of actin-myosin coupling, in the control state (10 pigs) and in a protocol of a 51-minute coronary occlusion followed by reperfusion (40 pigs). The effects on coronary artery blood flow in the basal state were also studied (seven pigs). Intramyocardial distribution of the infusate during coronary occlusion, myocardial water content after 30 minutes of reperfusion and area at risk, infarct size, type of histological necrosis, and infarct geometry after 24 hours of reperfusion were assessed. Methods used included electromagnetic flowmeter, radiolabeled microspheres, subendocardial sonomicrometers, fluorescein, triphenyl tetrazolium chloride and Masson's trichrome staining, and computer quantification of infarct edges. In the absence of ischemia, BDM infusion inhibited regional shortening in a dose-dependent manner up to full systolic bulging while producing marked regional increase in coronary blood flow. During early reperfusion, BDM reduced end-diastolic length 76% more than the control infusion (p less than 0.05) and increased systolic bulging by 420% compared with no change in control animals. The ratio of infarct size/area at risk was reduced by 31% with BDM (p less than 0.05), with striking modifications of infarct histology and infarct geometry; specifically, the extent of contraction band necrosis was reduced by 63% from 105.5 +/- 18.2 to 39.2 +/- 13.6 mm2 (p less than 0.02), and more patches of necrosis (6.5 +/- 2.1 versus 1.6 +/- 0.4, p less than 0.05) and higher contour (7.7 +/- 1.2 versus 5.03 +/- 0.2, p less than 0.05) and fractal (12.1 +/- 1.3 versus 7.8 +/- 0.2, p less than 0.05) indexes were found. CONCLUSIONS: Selective intracoronary infusion of BDM at doses inhibiting regional wall motion decreased infarct size after reperfusion. The effects of BDM on regional function, the reduction in contraction band necrosis at histology, and the peculiar configuration of these infarcts all suggest that inhibition of contracture can interfere with cell-to-cell progression of myocardial necrosis, supporting a role for contracture in reperfusion-induced cell death.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

García‐Dorado et al. (1992) studied this question.

synapsesocial.com/papers/6a7d1761ade38b7dc346cda0https://doi.org/10.1161/01.cir.85.3.1160
Ask AI
Helpful
Bookmark
Share
View Full Paper